Dr. Voravech Nissaisorakarn, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 103 Garland St, Everett, MA 02149 Phone: 617-389-6270 |
News Archive
Now, a new study published on the preprint server bioRxiv* in August 2020 reports the induction of neutralizing antibodies in mice by a single dose of a ferritin nanoparticle-based vaccine containing the spike protein.
We know that there are many ways in which cancer can be prevented, but how many cancers can we prevent? And what do we have to do to really have an impact on reducing the burden of this disease? A special issue of Preventive Medicine, published by Elsevier, responds to these questions, showcasing results from the Canadian Population Attributable Risk of Cancer project—the most comprehensive, up-to-date estimate of the preventable burden of cancer in Canada.
Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding ISTODAX (romidepsin) for injection for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.
Jose Ramon Sarasua and Aitor Larra-aga, researchers in the materials engineering department of the UPV/EHU-University of the Basque Country, have been studying new materials or implants that are of interest in medicine and in helping to mend bones, in particular.
› Verified 3 days ago